9-34517291-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000242317.9(DNAI1):c.1825A>T(p.Ile609Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000109 in 1,461,568 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I609V) has been classified as Likely benign.
Frequency
Consequence
ENST00000242317.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.1825A>T | p.Ile609Leu | missense_variant | 19/20 | ENST00000242317.9 | NP_036276.1 | |
DNAI1 | NM_001281428.2 | c.1837A>T | p.Ile613Leu | missense_variant | 19/20 | NP_001268357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAI1 | ENST00000242317.9 | c.1825A>T | p.Ile609Leu | missense_variant | 19/20 | 1 | NM_012144.4 | ENSP00000242317 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461568Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727058
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 11, 2013 | The Ile609Leu variant in DNAI1 has not been previously identified in individuals with pulmonary disease or in large population studies. This residue is poorly c onserved in evolution, suggesting that the change may be tolerated. Computation al analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) suggest that the variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, additional informat ion is needed to fully assess the clinical significance of this variant. - |
Kartagener syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Mar 30, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at